Back to search
FDAFDA · Food and drugs·Recall number Z-1720-2016

Accriva- APTT Cuvette for use on the Hemochron Jr. test system, catalog #J103, lot B6JCA012.

Published June 1, 2016 · Recall initiated: April 22, 2016

Summary

FDA records medical device Class II recall Z-1720-2016, published June 1, 2016 and initiated April 22, 2016. Recalling firm: Accriva Diagnostics Inc., dba ITC, dba Accumetrics; Status: Terminated; Reported quantity: 135 boxes; Lot: Lot #B6JCA012. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Clot activating reagent mis-positioned or visibly absent in the cuvette's test channel causing APTT test to either have an error code or an erroneously high result.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Accriva Diagnostics Inc., dba ITC, dba Accumetrics
Distributor
U.S. distribution to the following; state: VA. Foreign distribution to the following; China, Italy, Germany.
Lot
Lot #B6JCA012
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Accriva- APTT Cuvette for use on the Hemochron Jr. test system, catalog #J103, lot B6JCA012. recalled?

Yes. FDA published recall Z-1720-2016 on June 1, 2016. Reported hazard: Clot activating reagent mis-positioned or visibly absent in the cuvette's test channel causing APTT test to either have an error code or an erroneously high result.

What should I do if I have this product?

Voluntary: Firm initiated · Letter